Cell density-dependent increase in tyrosine-monophosphorylated ERK2 in MDCK Cells expressing active ras or raf

PLoS ONE

Volumn 11, Issue 12, 2016, Pages

  Kawabata, Noriyuki ^a   Matsuda, Michiyuki ^a  

^a KYOTO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

B RAF KINASE; CALYCULIN A; K RAS PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE 1; RAF PROTEIN; RAS PROTEIN; THREONINE; TYROSINE; PROTEIN KINASE B; S6 KINASE;

ANIMAL CELL; ARTICLE; BIOSENSOR; CELL DENSITY; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; FORSTER RESONANCE ENERGY TRANSFER; IMAGE PROCESSING; MDCK CELL LINE; NONHUMAN; ONCOGENE H RAS; ONCOGENE K RAS; ONCOGENE N RAS; POLYACRYLAMIDE GEL ELECTROPHORESIS; PROTEIN ANALYSIS; PROTEIN DEPHOSPHORYLATION; PROTEIN EXPRESSION; WESTERN BLOTTING; ANIMAL; DOG; METABOLISM; PHOSPHORYLATION; WOUND HEALING;

ANIMALS; DOGS; MADIN DARBY CANINE KIDNEY CELLS; MITOGEN-ACTIVATED PROTEIN KINASE 1; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS B-RAF; PROTO-ONCOGENE PROTEINS C-AKT; RAS PROTEINS; RIBOSOMAL PROTEIN S6 KINASES; TYROSINE; WOUND HEALING;

EID: 85006038147     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0167940     Document Type: Article

References (49)

1. Bos JL. ras oncogene in human cancer: a review. Cancer Res. 1989; 49: 4682-4689. PMID: 2547513
2. Garnett MJ, Marais R. Guilty as charged: B-RAF is a human oncogene. Cancer Cell. 2004; 6: 313-319. doi: 10.1016/j.ccr.2004.09.022 PMID: 15488754
3. Nishida E, Gotoh Y. The MAP kinase cascade is essential for diverse signal transduction pathways. Trends Biochem Sci. 1993; 18: 128-131. PMID: 8388132
4. Sebolt-Leopold JS, Herrera R. Targeting the mitogen-activated protein kinase cascade to treat cancer. Nat Rev Cancer. 2004; 4: 937-947. doi: 10.1038/nrc1503 PMID: 15573115
5. Schubbert S, Shannon K, Bollag G. Hyperactive Ras in developmental disorders and cancer. Nat Rev Cancer. 2007; 7: 295-308. doi: 10.1038/nrc2109 PMID: 17384584
6. Houben R, Vetter-Kauczok CS, Ortmann S, Rapp UR, Broecker EB, Becker JC. Phospho-ERK staining is a poor indicator of the mutational status of BRAF and NRAS in human melanoma. J Invest Dermatol. 2008; 128: 2003-2012. doi: 10.1038/jid.2008.30 PMID: 18323787
7. Smalley KS, Contractor R, Haass NK, Lee JT, Nathanson KL, Medina CA, et al. Ki67 expression levels are a better marker of reduced melanoma growth following MEK inhibitor treatment than phospho-ERK levels. Br J Cancer. 2007; 96: 445-449. doi: 10.1038/sj.bjc.6603596 PMID: 17245336
8. Kholodenko BN. Negative feedback and ultrasensitivity can bring about oscillations in the mitogen-activated protein kinase cascades. Eur J Biochem. 2000; 267: 1583-1588. PMID: 10712587
9. Ahmed S, Grant KG, Edwards LE, Rahman A, Cirit M, Goshe MB, et al. Data-driven modeling reconciles kinetics of ERK phosphorylation, localization, and activity states. Mol Syst Biol. 2014; 10: 718. doi: 10.1002/msb.134708 PMID: 24489118
10. Mandell JW. Immunohistochemical assessment of protein phosphorylation state: the dream and the reality. Histochem Cell Biol. 2008; 130: 465-471. doi: 10.1007/s00418-008-0474-z PMID: 18648845
11. Eagle H, Levine EM. Growth regulatory effects of cellular interaction. Nature. 1967; 213: 1102-1106. PMID: 6029791
12. Abercrombie M. Contact inhibition and malignancy. Nature. 1979; 281: 259-262. PMID: 551275
13. Wayne J, Sielski J, Rizvi A, Georges K, Hutter D. ERK regulation upon contact inhibition in fibroblasts. Mol Cell Biochem. 2006; 286: 181-189. doi: 10.1007/s11010-005-9089-z PMID: 16467968
14. Li S, Gerrard ER Jr., Balkovetz DF. Evidence for ERK1/2 phosphorylation controlling contact inhibition of proliferation in Madin-Darby canine kidney epithelial cells. Am J Physiol Cell Physiol. 2004; 287: C432-439. doi: 10.1152/ajpcell.00020.2004 PMID: 15070810
15. Vinals F, Pouyssegur J. Confluence of vascular endothelial cells induces cell cycle exit by inhibiting p42/p44 mitogen-activated protein kinase activity. Mol Cell Biol. 1999; 19: 2763-2772. PMID: 10082542
16. Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2011; 144: 646-674. doi: 10. 1016/j.cell.2011.02.013 PMID: 21376230
17. Pastan I, Willingham M. Cellular transformation and the 'morphologic phenotype' of transformed cells. Nature. 1978; 274: 645-650. PMID: 209337
18. Cooper GM. Cellular transforming genes. Science. 1982; 217: 801-806. PMID: 6285471
19. McCoy MS, Toole JJ, Cunningham JM, Chang EH, Lowy DR, Weinberg RA. Characterization of a human colon/lung carcinoma oncogene. Nature (London). 1983; 302: 79-81.
20. Oldach L, Zhang J. Genetically encoded fluorescent biosensors for live-cell visualization of protein phosphorylation. Chem Biol. 2014; 21: 186-197. doi: 10.1016/j.chembiol.2013.12.012 PMID: 24485761
21. Miyawaki A, Niino Y. Molecular spies for bioimaging-fluorescent protein-based probes. Mol Cell. 2015; 58: 632-643. doi: 10.1016/j.molcel.2015.03.002 PMID: 26000848
22. Harvey CD, Ehrhardt AG, Cellurale C, Zhong H, Yasuda R, Davis RJ, et al. A genetically encoded fluorescent sensor of ERK activity. Proc Natl Acad Sci U S A. 2008; 105: 19263-19268.
23. Komatsu N, Aoki K, Yamada M, Yukinaga H, Fujita Y, Kamioka Y, et al. Development of an optimized backbone of FRET biosensors for kinases and GTPases. Mol Biol Cell. 2011; 22: 4647-4656. doi: 10. 1091/mbc.E11-01-0072 PMID: 21976697
24. Fujioka A, Terai K, Itoh RE, Aoki K, Nakamura T, Kuroda S, et al. Dynamics of the Ras/ERK MAPK cascade as monitored by fluorescent probes. J Biol Chem. 2006; 281: 8917-8926. doi: 10.1074/jbc. M509344200 PMID: 16418172
25. Aoki K, Kumagai Y, Sakurai A, Komatsu N, Fujita Y, Shionyu C, et al. Stochastic ERK activation induced by noise and cell-to-cell propagation regulates cell density-dependent proliferation. Mol Cell. 2013; 52: 529-540. doi: 10.1016/j.molcel.2013.09.015 PMID: 24140422
26. Albeck JG, Mills GB, Brugge JS. Frequency-Modulated Pulses of ERK Activity Transmit Quantitative Proliferation Signals. Mol Cell. 2013; 19: 249-261.
27. Hiratsuka T, Fujita Y, Naoki H, Aoki K, Kamioka Y, Matsuda M. Intercellular propagation of extracellular signal-regulated kinase activation revealed by in vivo imaging of mouse skin. Elife. 2015; 4: e05178. doi: 10.7554/eLife.05178 PMID: 25668746
28. Yusa K, Rad R, Takeda J, Bradley A. Generation of transgene-free induced pluripotent mouse stem cells by the piggyBac transposon. Nature Methods. 2009; 6: 363-369. doi: 10.1038/nmeth.1323 PMID: 19337237
29. Urasaki A, Morvan G, Kawakami K. Functional dissection of the Tol2 transposable element identified the minimal cis-sequence and a highly repetitive sequence in the subterminal region essential for transposition. Genetics. 2006; 174: 639-649. doi: 10.1534/genetics.106.060244 PMID: 16959904
30. Shaner NC, Campbell RE, Steinbach PA, Giepmans BN, Palmer AE, Tsien RY. Improved monomeric red, orange and yellow fluorescent proteins derived from Discosoma sp. red fluorescent protein. Nat Biotechnol. 2004; 22: 1567-1572. doi: 10.1038/nbt1037 PMID: 15558047
31. Akagi T, Sasai K, Hanafusa H. Refractory nature of normal human diploid fibroblasts with respect to oncogene-mediated transformation. Proc Natl Acad Sci U S A. 2003; 100: 13567-13572. doi: 10.1073/ pnas.1834876100 PMID: 14597713
32. Matsuda T, Cepko CL. Controlled expression of transgenes introduced by in vivo electroporation. Proc Natl Acad Sci U S A. 2007; 104: 1027-1032. doi: 10.1073/pnas.0610155104 PMID: 17209010
33. Sakurai A, Matsuda M, Kiyokawa E. Activated ras protein accelerates cell cycle progression to perturb madin-darby canine kidney cystogenesis. J Biol Chem. 2012; 287: 31703-31711. doi: 10.1074/jbc. M112.377804 PMID: 22829590
34. Aoki K, Yamada M, Kunida K, Yasuda S, Matsuda M. Processive phosphorylation of ERK MAP kinase in mammalian cells. Proc Natl Acad Sci U S A. 2011; 108: 12675-12680. doi: 10.1073/pnas. 1104030108 PMID: 21768338
35. Aoki K, Matsuda M. Visualization of small GTPase activity with fluorescence resonance energy transfer-based biosensors. Nature Protocol. 2009; 4: 1623-1631.
36. Mochizuki N, Yamashita S, Kurokawa K, Ohba Y, Nagai T, Miyawaki A, et al. Spacio-temporal images of growth factor-induced activation of Ras and Rap1. Nature (London). 2001; 411: 1065-1068.
37. Iwamoto N, D'Alessandro LA, Depner S, Hahn B, Kramer BA, Lucarelli P, et al. Context-specific flow through the MEK/ERK module produces cell- and ligand-specific patterns of ERK single and double phosphorylation. Science Signaling. 2016; 9: ra13-ra13. doi: 10.1126/scisignal.aab1967 PMID: 26838549
38. Brautigan DL. Protein Ser/Thr phosphatases-the ugly ducklings of cell signalling. The FEBS J. 2013; 280: 324-345. doi: 10.1111/j.1742-4658.2012.08609.x PMID: 22519956
39. Shi Y. Serine/threonine phosphatases: mechanism through structure. Cell. 2009; 139: 468-484. doi: 10.1016/j.cell.2009.10.006 PMID: 19879837
40. Cohen P, Klumpp S, Scelling DL. An improved procedure for identifying and quantitating protein phosphatases in mammalian tissues. FEBS Lett. 1989; 250: 596-600. PMID: 2546812
41. Ishihara H, Martin BL, Brautigan DL, Karaki H, Ozaki H, Kato Y, et al. Calyculin A and okadaic acid: inhibitors of protein phosphatase activity. Biochem Biophys Res Commun. 1989; 159: 871-877. PMID: 2539153
42. Swingle M, Ni L, Honkanen RE. Small Molecule Inhibitors of Ser/thr Protein Phosphatases: Specificity, Use and Common Forms of Abuse. Methods Mol Biol (Clifton, NJ). 2007; 365: 23-38.
43. Kinzler KW, Vogelstein B. Lessons from Hereditary Colorectal Cancer. Cell. 1996; 87: 159-170. PMID: 8861899
44. Burd CE, Liu W, Huynh M V, Waqas MA, Gillahan JE, Clark KS, et al. Mutation-specific RAS oncogenicity explains NRAS codon 61 selection in melanoma. Cancer Discov. 2014; 4: 1418-1429. doi: 10.1158/ 2159-8290.CD-14-0729 PMID: 25252692
45. Perrotti D, Neviani P. Protein phosphatase 2A: a target for anticancer therapy. Lancet Oncol. 2013; 14: e229-238. doi: 10.1016/S1470-2045(12)70558-2 PMID: 23639323
46. Ceulemans H, Bollen M. Functional Diversity of Protein Phosphatase-1, a Cellular Economizer and Reset Button. Physiol Rev. 2004; 84: 1-39. doi: 10.1152/physrev.00013.2003 PMID: 14715909
47. Jaumot M, Hancock JF. Protein phosphatases 1 and 2A promote Raf-1 activation by regulating 14-3-3 interactions. Oncogene. 2001; 20: 3949-3958. doi: 10.1038/sj.onc.1204526 PMID: 11494123
48. Chuang M-J, Wu S-T, Tang S-H, Lai X-M, Lai H-C, Hsu K-H, et al. The HDAC Inhibitor LBH589 Induces ERK-Dependent Prometaphase Arrest in Prostate Cancer via HDAC6 Inactivation and Down-Regulation. PLoS One. 2013; 8: e73401. doi: 10.1371/journal.pone.0073401 PMID: 24023871
49. Valjent E, Pascoli V, Svenningsson P, Paul S, Enslen H, Corvol J-C, et al. Regulation of a protein phosphatase cascade allows convergent dopamine and glutamate signals to activate ERK in the striatum. Proc Natl Acad Sci U S A. 2005; 102: 491-496. doi: 10.1073/pnas.0408305102 PMID: 15608059